Tradjenta (Linagliptin) for Diabetes

Overview
Tradjenta is a prescription drug approved by the Food and Drug Administration (FDA) to help improve blood glucose control in adults with type 2 diabetes. Tradjenta is considered an adjunct treatment to diet and exercise. Tradjenta is also referred to by its drug name, Linagliptin.

Tradjenta is a dipeptidyl peptidase 4 (DPP-4) inhibitor. Tradjenta is believed to work by lowering blood glucose levels when they are elevated.

How do I take it?
Prescribing information states that Tradjenta is generally taken once daily with or without food.

Tradjenta comes in tablet form.

Side effects
The FDA-approved label for Tradjenta lists common side effects including flu-like symptoms, upper respiratory infection, and headache.

Rare but serious side effects listed for Tradjenta include pancreatitis, liver problems, and systemic allergic reaction.